Company: HCTI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001213900-25-099128
Chunk: 16

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 16
---
 to Compensation Policies and Practices

In establishing and reviewing our compensation
philosophy and programs, we consider whether such programs encourage unnecessary or excessive risk taking. We believe that our executive
compensation program does not encourage excessive or unnecessary risk taking. This is primarily due to the fact that our compensation
programs are designed to encourage our executive officers and other employees to remain focused on both short- term and long-term strategic
goals. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on us.

Board Committees

Our Board of Directors has established three
standing committees: audit, leadership and compensation, and nominating and corporate governance. We have appointed people to the
Board of Directors and committees of the Board of Directors as required to meet the corporate governance requirements of the Nasdaq.
The audit committee, compensation committee and nominating and corporate governance committee all operate under charters approved by
our Board of Directors (copies of which can be found on our website by visiting
https://www.healthcaretriangle.com/investors/governence/policies. During the fiscal year ended December 31, 2024, the audit
committee met 4 times, the compensation committee met once, and the nominating and corporate governance committee met once. During
their respective terms of service, each director attended at least 75% of all meetings of the committees on which they then served,
which were held during 2024. Our Board of Directors may from time to time establish other committees.

Board and Committee Evaluations

The nominating and corporate governance committee
intends to establish the Board and committee evaluation process and may determine to use an independent third-party evaluation process
from time to time in the future. No board or committee evaluations were undertaken in 2024.

<div align='center'>10</div>

Director Attendance at Annual Meeting of Stockholders

Directors are encouraged to attend the annual meeting of stockholders
to the extent practicable. We held an annual meeting of stockholders in 2024 as we were a public company.

Audit Committee

We have a separately designated standing audit
committee of our Board of Directors, as defined in Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (“Exchange Act”). The audit committee is currently comprised of three independent directors: Ronald McClurg, Jainal Bhuiyan, Dave Rosa.
Mr. McClurg is the Chair of our audit committee. Our Board of Directors have determined that each of